Fournier Gangrene

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Fournier Gangrene trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07359651

FATAL-NSTI Study (Factors Associated With In-hospital mortALity in NSTI).

Necrotizing soft tissue infections (NSTIs) are rare but potentially life-threatening infections involving the skin and underlying tissues such as fat, fascia, a…

Italy300 participantsStarted 2020-01-01

Treatment: No Intervention: Observational Cohort

All recent trials (15 shown)

By InvitationNot Applicable

NCT07107555

Necrotizing Soft Tissue Infections

SnapNSTI is an international, multicenter, time-bound prospective observational cohort study designed to characterize current epidemiology, management patterns,…

Spain480 participantsStarted 2026-01-01

CompletedPhase 3

NCT06809738

Anatomical Scale for the Prognosis of Fournier Syndrome.

Type of study: Case series. Universe of study: Records of patients with Fournier syndrome treated using the 3-stage reconstructive technique assigned and treate…

Mexico58 participantsStarted 2021-01-01

Treatment: reconstructive technique

Fournier Gangrene

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

FATAL-NSTI Study (Factors Associated With In-hospital mortALity in NSTI).

All recent trials (15 shown)

Necrotizing Soft Tissue Infections

Anatomical Scale for the Prognosis of Fournier Syndrome.

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

FATAL-NSTI Study (Factors Associated With In-hospital mortALity in NSTI).

All recent trials (15 shown)

Necrotizing Soft Tissue Infections

Anatomical Scale for the Prognosis of Fournier Syndrome.

The Immunological Differences Between Fournier Gangrene and Perianal Abscess

Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections

SKin and Soft Tissue Necrotizing INfections in the Intensive Care Unit: a Prospective Multi-national Cohort Study

Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections

Management of Fournier Gangrene at Ibn Rochd University Hospital Center

Fournier's Gangrene in Patient With Uncontrolled Type 2 Diabetes

Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study

Modulation of Biomarkers in Patients With Flesh-eating Bacterial Infections After With Hyperbaric Oxygen Treatment

Fournier's Gangrene and the Origin of the Infection as a Prognostic of Morbidity and Mortality, an Analysis of 121 Patie…

Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial

Biomarkers in Patients With Flesh-eating Bacterial Infections

Exploratory Study of Raised Serum Lactate as a Marker of Necrotizing Fasciitis